Neurons of the sensory ganglia are the major site of varicella-zoster virus (VZV) latency and may undergo productive infection during reactivation. Although the VZV glycoprotein E/glycoprotein I (gE/gI) complex is known to be critical for neurovirulence, few studies have assessed the roles of these proteins during infection of dorsal root ganglia (DRG) due to the high human specificity of the virus. Here, we show that the VZV glycoprotein I gene is an important neurotropic gene responsible for mediating the spread of virus in neuronal cultures and explanted DRG. Inoculation of differentiated SH-SY5Y neuronal cell cultures with a VZV gI gene deletion strain (VZV rOka⌬gI) showed a large reduction in the percentage of cells infected and significantly smaller plaque sizes in a comparison with cultures infected with the parental strain (VZV rOka). In contrast, VZV rOka⌬gI was not significantly attenuated in fibroblast cultures, demonstrating a cell type-specific role for VZV gI. Analysis of rOka⌬gI protein localization by immunofluorescent staining revealed aberrant localization of viral glycoprotein and capsid proteins, with little or no staining present in the axons of differentiated SH-SY5Y cells infected with rOka⌬gI, yet axonal vesicle trafficking was not impaired. Further studies utilizing explanted human DRG indicated that VZV gI is required for the spread of virus within DRG. These data demonstrate a role for VZV gI in the cell-to-cell spread of virus during productive replication in neuronal cells and a role in facilitating the access of virion components to axons. V aricella-zoster virus (VZV) is the etiological agent of the human disease varicella (chickenpox) (1). Following primary infection, the virus establishes latency within neurons of the sensory ganglia (2, 3), from where it may reactivate to result in the secondary clinical disease herpes zoster (shingles) (4). Herpes zoster may be followed by a state of debilitating, long-term pain known as postherpetic neuralgia (PHN), which is commonly resistant to many traditional pain therapies (3, 5, 6) .
V aricella-zoster virus (VZV) is the etiological agent of the human disease varicella (chickenpox) (1) . Following primary infection, the virus establishes latency within neurons of the sensory ganglia (2, 3) , from where it may reactivate to result in the secondary clinical disease herpes zoster (shingles) (4) . Herpes zoster may be followed by a state of debilitating, long-term pain known as postherpetic neuralgia (PHN), which is commonly resistant to many traditional pain therapies (3, 5, 6) .
VZV glycoprotein I (gI) is a type I membrane protein encoded by open reading frame 67 (ORF67) and functions primarily as a heterodimer with the most abundant VZV protein, gE (7) . Although gI is dispensable in cell culture, deletion of the gene results in an impairment of syncytium formation, delayed replication, and a decrease in infectious virus yields within melanoma cells (8) . In the context of neuronal infection, gI has been shown to be dispensable in a rat model of persistent VZV infection, although this host is nonpermissive (9) . In a severe combined-immunodeficiency human (SCIDhu) mouse model of VZV infection utilizing human-xenografted dorsal root ganglia (DRG), infection with a VZV mutant lacking the gI gene (rOka⌬gI) resulted in prolonged replication within the DRG and an inability to transition to a persistent state, normally characterized by limited viral transcription (10) . In addition, mutation of the cysteine-rich region in VZV gE responsible for gE/gI heterodimer formation impaired cell-to-cell spread of virus in DRG (11) .
Studies assessing the herpes simplex virus (HSV) and pseudorabiesvirus (PRV) homologs of gI have reported important functions in mediating anterograde axonal egress during neuronal infection. HSV infection of neurons using compartmentalized chamber systems and rat models have demonstrated that gI is essential for anterograde spread of virus (12) . Studies of HSV have demonstrated that the gE/gI heterodimer is required for transport of the viral proteins gB and gD as well as viral capsids (13) . PRV gE/gI deletion viruses are also impaired in anterograde spread in rat models of retinal infection, despite no impairment of retrograde transport or replication within retinal ganglion neurons (14, 15) . Similarly, deletion of the PRV gI gene results in impairment of anterograde spread by compartmentalized chamber systems (16, 17) . However, VZV interactions within neuronal axons have been poorly defined to date due to the high human specificity of the virus, which places limitations on the models available to assess VZV neuronal infection (1, 18) .
A number of cell culture models have recently been developed for the assessment of VZV-neuron interactions. VZV infections of differentiated human neural stem cells (19) and terminally differentiated neurons derived from induced pluripotent stem cells (20, 21) have been reported as persistent models of VZV infection. In contrast, human embryonic stem cell (22) and differentiated human neuroblastoma (23)-derived neuronal cells induced productive VZV infection under the study conditions utilized. The differentiated SH-SY5Y neuroblastoma cell culture model previously developed by our laboratory may be particularly useful to assess the neurovirulence of VZV deletion strains or mutant strains during productive VZV infection (23) . Here, we utilize this model to detail the requirements of gI during VZV neuronal infection using the parental strain rOka and the gI deletion strain rOka⌬gI (8) . Flow cytometry and infectious-center assays were used to demonstrate a cell type-specific role for VZV gI in mediating the spread of virus between neuronal cells. Furthermore, immunofluorescent staining and confocal microscopy identified a role for VZV gI in facilitating the access of virion proteins to axons. Experiments utilizing DRG from explanted primary human fetal samples (24) to assess the role of VZV gI in an ex vivo setting where the natural architecture of the ganglia is preserved support the hypothesis that gI is an important VZV protein required for cell-to-cell spread of the virus between ganglionic cells.
MATERIALS AND METHODS
Cell and virus culture. SH-SY5Y cells were differentiated as previously described and cultures established by inoculating 1 ϫ 10 5 cells/coverslip in 24-well culture plates (23) . In parallel, cultures of human foreskin fibroblasts (HFFs) were similarly established by inoculating 1 ϫ 10 5 cells/ coverslip in 24-well culture plates. HFFs were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Australia) containing fetal calf serum (FCS; 10%, vol/vol; In Vitro Technologies, Australia) and penicillin-streptomycin (50 IU/ml; Gibco, Australia) and were allowed to adhere overnight prior to infection.
VZV rOka and rOka⌬gI (8) were propagated in HFFs in DMEM containing FCS (10%, vol/vol) and penicillin-streptomycin (50 IU/ml) and were harvested for infection experiments when 80 to 90% of the monolayers exhibited cytopathic effects (CPE). Infected or uninfected (mockinfected) cultures were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE; Sigma-Aldrich, Australia) and then inoculated onto either differentiated SH-SY5Y or HFF cultures at a density of 1 ϫ 10 5 cells/well or at a final 1:1 ratio of infected cells to uninfected cells. Coverslips were harvested at various times postinoculation (p.i.) for analysis.
Immunostaining and flow cytometry. Triplicate wells containing differentiated SH-SY5Y cells or HFFs inoculated with CFSE-labeled mock-, rOka-, or rOka⌬gI-infected HFFs were pooled at either 24, 48, or 72 h p.i. and fixed in 1% paraformaldehyde (PFA; BD Biosciences, Australia) for 20 min. Prior to being immunostained, cells were permeabilized in saponin buffer (PBS containing 1% FCS, 0.2% sodium azide [Sigma-Aldrich, Australia], 10 mM EDTA [Gibco, Australia], and 0.3% saponin [Sigma-Aldrich, Australia]) for 10 min. To quantify the proportion of VZV antigen-positive cells, samples were separately stained in saponin buffer with a mouse anti-VZV primary antibody specific to the immediate early IE62 protein [clone IE(62), 1:50; Meridian Life Science, United States] or a mouse anti-VZV primary antibody specific to late gE and gI proteins (clone SG1, 1:200; Meridian Life Sciences, United States). The gE-and gI-specific antibody used in this study is documented to individually react with both the precursor and the mature forms of gE and gI. Cells were incubated at 4°C for an hour, washed in PBS, and then incubated with a goat anti-mouse Alexa Fluor 647-conjugated antibody (1:200; Life Technologies, Australia) in saponin buffer at 4°C for an hour. Cells were washed in PBS, filtered, and processed using a FACSCanto cytometer and analyzed using FACSDiva software. Specificity of staining was confirmed by assessing isotype antibody-treated cultures at corresponding concentrations. All statistical analysis was performed using a paired, 2-tailed Student t test.
Infectious-center assay. Coverslips containing cultures of either differentiated SH-SY5Y cells or HFFs were inoculated with serial 1-in-10 dilutions of mock-, rOka-, or rOka⌬gI-infected HFFs. Cultures were left to incubate for 96 h and were then fixed in 4% PFA for 20 min. Single-immunofluorescence staining was performed using a primary antibody against VZV gE and gI (1:600; Meridian Life Sciences, United States) followed by a donkey anti-mouse Alexa Fluor 594-conjugated secondary antibody (1:200; Life Technologies, Australia). Specificity of staining was confirmed by assessing isotype antibody-treated cultures at corresponding concentrations. Coverslips were mounted with Prolong Gold antifade reagent containing 4=,6-diamidino-2-phenylindole, dihydrochloride (DAPI; Life Technologies, Australia). Infectious centers were imaged and counted using a Zeiss LSM 510 Meta confocal microscope. Approximately 10 infectious centers per sample were randomly selected, and the area was quantified using Zeiss AxioVision software. All statistical analysis was performed using a paired, 2-tailed Student t test.
Immunofluorescence staining and confocal microscopy. Coverslips containing differentiated SH-SY5Y cells inoculated with CFSE-labeled mock-, rOka-, or rOka⌬gI-infected HFFs were fixed in 4% PFA for 20 min. Cells were washed in PBS, permeabilized, and blocked in PBS containing 0.1% Triton X-100 and 20% normal donkey serum (NDS) Dual-immunofluorescence staining was performed using the VZV antibodies utilized in single-immunofluorescence experiments in combination with rabbit antibodies specific to syntaxin-6 (clone C34B2, 1:100; Cell Signaling, United States), synaptophysin (clone Z66, 1:10; Invitrogen, Australia), or chromogranin A (N terminus, 1:200; Abcam, United Kingdom). Coverslips incubated with syntaxin-6 antibody were incubated overnight at 4°C, or coverslips incubated with synaptophysin or chromogranin A were incubated for an hour at room temperature, under humidified conditions. Primary antibodies were detected with donkey anti-rabbit Alexa Fluor 647 (1:200; Life Technologies, Australia)-conjugated and donkey anti-mouse Alexa Fluor 546 (1:200; Life Technologies, Australia)-conjugated secondary antibodies applied for 30 min at 37°C. Specificity of staining was confirmed by using isotype antibody-treated cultures at corresponding concentrations. All coverslips were mounted with Prolong Gold antifade reagent containing DAPI.
Fluorescence images were acquired using a Zeiss LSM 510 Meta confocal microscope. Areas containing abundant axonal processes were identified by transmitted-light imaging with differential interference contrast (DIC) and were chosen for further analysis. Image analysis was performed using Zeiss AxioVision software.
Explanted-DRG culture and immunofluorescence staining. Human fetal spinal tissue was obtained at 15 to 20 weeks of the gestational period after informed consent and approval by the University of Sydney Human Ethics Committee were obtained. DRG were dissected and explanted as previously described (24) . Four days postplating, DRG exhibiting extensive axonal outgrowth were infected with either mock-, rOka-, or rOka⌬gI-infected HFFs at a density of 1 ϫ10
5 HFFs/well. DRG were formalin fixed at 96 h p.i. and paraffin embedded, and 5-m sections were microtomed and then collected onto microscope slides.
Immediately preceding immunofluorescent staining of DRG, sections were dewaxed in histolene and rehydrated in a gradient of decreasing ethanol dilutions. Unmasking was performed in citrate buffer (pH 6) at 95°C. Sections were blocked in 20% NDS in Tris-buffered saline (TBS) for an hour at room temperature. VZV infection was detected using a rabbit anti-VZV pORF62-specific antibody (1:200; kindly provided by P. Kinchington, University of Pittsburgh) or a mouse anti-VZV gE-specific antibody (1:10; Millipore, Australia). In conjunction, a mouse anti-neural cell adhesion molecule (anti-NCAM)-specific antibody (clone 123C3, 1:20; Cell Signaling, Australia) or a rabbit anti-S100B-specific polyclonal antibody (predilute; Dako, Denmark) were utilized. Primary antibodies were applied for 2 h at room temperature under humidified conditions. Donkey anti-mouse Alexa Fluor 488-conjugated and donkey anti-rabbit Alexa Values are means, with error bars showing the standard errors of the means from three independent experiments. Significant difference was determined using a paired, two-tailed Student t test (*, P Ͻ 0.05; **, P Ͻ 0.01). Australia) were used for detection by incubation at room temperature for 30 min. Specificity of staining was confirmed by using isotype antibodytreated sections at corresponding concentrations. Sections were mounted with Prolong Gold antifade reagent containing DAPI and sealed with coverslips. Images were acquired using a Zeiss LSM 510 Meta confocal microscope and were analyzed using Zeiss AxioVision software.
RESULTS

VZV infection of neuronal cells is significantly impaired in the absence of gI.
To assess the kinetics of VZV infection in neuronal cultures, HFFs infected with the VZV gI deletion virus rOka⌬gI (8) or the parental virus rOka or mock-infected HFFs were CFSE labeled and inoculated onto differentiated SH-SY5Y neuronal cultures as previously described (23) . Within inoculating cultures, the percentage of infected cells ranged from 77 to 91%, with less than 5% variation in the infection level of viral strains used for each independent replicate experiment. In parallel, cultures of HFFs were inoculated at the same ratio of infection. Immunostaining was performed for cultures at 24, 48, and 72 h p.i. using antibodies for immediate early (IE62)-and late (gE/gI)-class VZV proteins, and the proportions of VZV antigen-positive (CFSEnegative) cells were quantified by flow cytometry. While the gEgI antibody reacts with both gE and gI, we did not observe any difference in staining efficiency of cells infected with parental or gI deletion viruses. Results are the collation of data from three independent experiments, with the same inoculating cultures used to infect both HFF and SH-SY5Y cells in parallel experiments.
In HFF cultures, very little difference in the percentages of cells infected with rOka and rOka⌬gI was observed at 24 h p.i. However, a slight reduction in VZV infection was observed in cultures inoculated with rOka⌬gI compared with that in cultures inoculated with rOka for both antibodies tested at 48 and 72 h p.i. Representative flow cytometry scatter plots are shown for VZV IE62 staining of HFFs at 72 h p.i. inoculated with mock-, rOka-, and rOka⌬gI-infected HFFs (Fig. 1A) . By 72 h p.i., the average percentage of VZV IE62-positive cells in rOka-inoculated cultures was 35% (Fig. 1B) , with the gE-and gI-specific antibody detecting 48% of HFFs that were VZV positive (Fig. 1C) . In rOka⌬gI-inoculated cultures, the average proportion of VZV IE62-positive cells at 72 h p.i. was 23% (Fig. 1B) , with 34% of cells being VZV gE and gI positive (Fig. 1C) . No VZV-specific staining was observed in mock-infected cultures (Fig. 1A) .
In neuronal cell cultures, a statistically significant difference in the percentages of cells infected was observed when levels of infection were compared between the two VZV strains, rOka and rOka⌬gI. Representative flow cytometry scatter plots are shown for VZV IE62 staining of SH-SY5Y cells at 72 h p.i. inoculated with CFSE-labeled mock-, rOka-, and rOka⌬gI-infected HFFs (Fig.  1D) . By 72 h p.i., an average of 48% of SH-SY5Y cells inoculated with rOka were VZV IE62 positive (Fig. 1E) , with 69% cells being VZV gE and gI positive (Fig. 1F) . Conversely, only 12% of SH-SY5Y cells inoculated with rOka⌬gI were VZV IE62 positive (Fig.  1E ) and only 20% of SH-SY5Y cells were VZV gE and gI positive (Fig. 1F) . No VZV-specific staining was observed in mock-infected cultures (Fig. 1D) . Overall, the reduction in the percentages of VZV IE62 antigen-positive cells infected with rOka⌬gI compared with those infected with rOka at 48 and 72 h p.i. correlated with a significant 3-fold and 4-fold decrease, respectively. Similarly, the percentage of VZV gE-and gI-positive cells in rOka⌬gI-inoculated cultures was found to amount to a 3.5-fold significant difference at 72 h p.i. in a comparison with rOka-infected cells.
The detection of both the immediate early VZV protein IE62 and late proteins gE and gI by flow cytometry in neuronal cell cultures infected with rOka⌬gI was indicative of a complete, productive VZV infection in these cells. Thus, it was hypothesized that the reduction of infection in neuronal cell cultures inoculated with VZV rOka⌬gI observed by flow cytometry was not due to an impediment of virus entry and/or replication.
VZV spread in neuronal cultures is significantly impaired in the absence of gI. To assess the ability of VZV rOka⌬gI to spread in neuronal cultures, we performed a series of infectious-center assays by inoculating HFFs infected with either rOka or rOka⌬gI onto monolayers of both HFFs and SH-SY5Y cells. Cultures were assessed at 96 h p.i. by immunofluorescent staining using a VZV gE-and gI-specific primary antibody. Approximately 10 infectious centers per culture were randomly selected and plaque areas quantified using Zeiss AxioVision software. Results were averaged for three independent experiments. HFFs inoculated with rOka⌬gI (Fig. 2B) 
FIG 2 Assessment of rOka and rOka⌬gI spread in HFFs and neuronal cells by
infectious-center assay. Serial dilutions of either rOka-or rOka⌬gI-infected HFFs were inoculated onto monolayers of either HFFs or differentiated neuronal cells. At 96 h p.i., coverslips were harvested and immunofluorescent staining was performed using an antibody specific to VZV gE and gI (red) and a DAPI counterstain (blue). Representative infectious centers are shown following infection of HFFs with either rOka (A) or rOka⌬gI (B) or following infection of neuronal cells with either rOka (C) or rOka⌬gI (D). (E) Infectious-center areas were quantified using Zeiss AxioVision software, and the mean values from three independent experiments were determined. Error bars show the standard errors of the means, and significant difference was determined using a paired, two-tailed Student t test (*, P Ͻ 0.05). exhibited a 1.9-fold average reduction in the size of infectious centers compared with those in cultures inoculated with rOka, although this decrease was not statistically significant ( Fig. 2A and E) . However, SH-SY5Y cells were found to support the spread of rOka (Fig. 2C ) much more efficiently than the spread of rOka⌬gI (Fig. 2D) , with a 6.8-fold average decrease in infectious-center area observed in rOka⌬gI-inoculated cultures compared with that in rOka-inoculated cultures (Fig. 2E) . Thus, it was concluded from these experiments that gI may play an important role in facilitating virus spread between neuronal cells.
VZV gI is required for viral glycoprotein and capsid protein localization to neuronal axons. As neuronal cells form extensive networks of axonal projections to facilitate cellular contact, we hypothesized that axons in these cultures might be important for efficient neuron-to-neuron spread of infection. We therefore sought to assess the axonal localization of structural virion proteins by performing immunofluorescent staining of differentiated neuronal cultures inoculated with either mock-, rOka-, or rOka⌬gI-infected HFFs. At 48 h p.i., coverslips containing cells were incubated with antibodies specific to VZV gB, gH, gE and gI, and the major capsid protein pORF40 and were analyzed by confocal microscopy. In order to confirm that the regions assessed within these cultures contained abundant axons, transmittedlight/DIC imaging was utilized to identify regions abundant in axonal processes, and cells containing visible axons were randomly selected for analysis.
In rOka-infected neuronal cells, staining for VZV gB (Fig. 3A) , gH (Fig. 3B) , and gE and gI (Fig. 3C ) was readily observed, with antigen localized predominantly to the cell surface and cytoplasm of the cell body. Clear punctate staining for these VZV proteins was also visible within the neuronal axons. pORF40 staining was predominately nuclear, with some cytoplasmic staining and axonal puncta also clearly visible (Fig. 3D) . In rOka⌬gI-infected neuronal cells, staining for VZV gB (Fig. 3E), gH (Fig. 3F) , and gE/gI (Fig. 3G) showed an aberrant localization of viral antigen within the cell cytoplasm. Specifically, VZV glycoproteins were found to accumulate in a nucleus-adjacent site, with limited expression on the neuronal surface. Although VZV glycoproteins were detected as puncta within a small number of neuronal axons, many axons projecting from infected cells contained little or no VZV glycoprotein-specific staining. Similarly, neuronal cells infected with rOka⌬gI were found to exhibit pORF40 antigen only within the nuclei of infected cells, with little or no antigen detected within either the cytoplasm or axons of infected neurons (Fig. 3H) .
To further examine the aberrant subcellular localization of VZV glycoprotein retention within the cytoplasm of neuronal cells infected with rOka⌬gI, dual-immunofluorescence staining
FIG 3 Assessment of viral capsid and glycoprotein localization in neuronal cells infected with rOka and rOka⌬gI. Either rOka (A to D)-, rOka⌬gI (E to K)-, or mock (L)-infected HFFs were labeled with CFSE (pseudocolored purple) and inoculated onto cultures of neuronal cells. (A to H)
Cultures were harvested at 48 h p.i. and immunostained using an antibody against VZV gB (A, E), gH (B, F), gE and gI (C, G), or pORF40 (pseudocolored green) (D, H) and were counterstained with DAPI (blue). Areas containing abundant axons were selected for imaging using a transmitted-light/DIC overlay (data not shown). (I to L) Cultures were immunostained for syntaxin-6 (pseudocolored green), with dual-immunofluorescence staining performed using antibodies specific for VZV gB (I), gH (J), or gE and gI (K) (red). Cell nuclei were visualized using a DAPI counterstain (blue). (L) No VZV-specific staining was observed in mock-infected cultures.
was performed using antibodies specific for VZV gB, gH, and gE/gI in conjunction with the trans-Golgi network (TGN) marker syntaxin-6. Confocal microscopy confirmed that there was abundant syntaxin-6 expression in mock-infected differentiated neuronal cells adjacent to the nucleus, indicative of a TGN-specific localization (Fig. 3L ). An identical localization of staining was observed for syntaxin-6 in cells infected with rOka⌬gI ( Fig. 3I to  K) . Furthermore, colocalization of syntaxin-6 was observed with each of the VZV glycoprotein-specific antibodies gB (Fig. 3I) , gH (Fig. 3J) , and gE and gI (Fig. 3K) within infected cells. No VZV glycoprotein staining was observed in mock-infected cultures (Fig. 3L) .
The combined data from three independent experiments demonstrated that gI is required for axonal localization of VZV glycoprotein and capsid proteins within infected neuronal cells. Furthermore, VZV glycoproteins localized aberrantly to the TGN of cells infected with VZV rOka⌬gI.
Axonal vesicle trafficking is not impaired in VZV rOka⌬gI-infected neuronal cells. To establish whether VZV glycoprotein retention within the TGN of rOka⌬gI-infected neuronal cells imparted a global effect on cellular TGN vesicle-derived trafficking pathways, we sought to identify whether cellular vesicle proteins could be detected within the axons of neuronal cells. Mock-, rOka-, or rOka⌬gI-infected SH-SY5Y cultures were assessed at 48 h p.i. by dual-immunofluorescence staining using antibodies against VZV gH in conjunction with the large dense-core vesicle marker chromogranin A (25) or the synaptic vesicle marker synaptophysin (26) .
Mock-infected neuronal cells exhibited punctate staining within the axons for both chromogranin A (Fig. 4E ) and synaptophysin (Fig. 4F) . Similar localization of staining was observed in the axons of neuronal cells infected with VZV rOka (Fig. 4A and  B) . As expected, VZV rOka-infected cells additionally contained punctate gH staining along the lengths of the axons. As determined previously, neuronal cells infected with VZV rOka⌬gI contained little or no gH-specific staining within the axons of infected cells (Fig. 3F) . However, chromogranin A (Fig. 4C ) and synaptophysin (Fig. 4D) were detectable as puncta within the axons of infected cells, with a distribution and intensity of staining indistinguishable from those of VZV rOka-infected cells (Fig. 4A and  B) . The results from three independent experiments indicated that VZV glycoprotein retention within the TGN of neuronal cells infected with rOka⌬gI does not appear to impair normal cellular vesicle trafficking pathways.
VZV cell-to-cell spread within human DRG is impaired in the absence of gI. To examine the role of gI in facilitating infection in the context of intact human DRG, we utilized a model of human fetal DRG explanted in vitro. Briefly, fetal DRG were harvested, explanted, and infected with either VZV rOka or rOka⌬gI as previously described (24) . DRG were formalin fixed and paraffin embedded at 96 h p.i. for assessment by immunofluorescent staining and confocal microscopy. To assess the localization of VZV antigen within the DRG at 96 h p.i., sections were immunostained with a VZV pORF62-specific antibody in conjunction with a neural cell adhesion molecule (NCAM) antibody. DRG infected with rOka exhibited areas of extensive VZV antigen positivity, suggesting that VZV readily underwent cell-to-cell spread (Fig. 5A) . In contrast, DRG infected with rOka⌬gI revealed limited pORF62 staining, which was consistently restricted to isolated cells within the DRG (Fig. 5B) . Staining and imaging of multiple consecutive sections verified that these isolated pORF62 antigen-positive cells were not in contact with any clusters of VZV-positive cells which may have undergone infection via cell-to-cell contact with inoculating fibroblasts at the DRG periphery. No VZV-specific staining was observed within mock-infected DRG (Fig. 5C) . To determine which cell types within the DRG center underwent productive VZV infection, DRG were immunostained at 96 h p.i. for VZV gE in conjunction with a S100B satellite cell marker. DRG infected with rOka showed localization of gE to both satellite cells and adjacent neurons (Fig. 5D) . In contrast, in DRG infected with rOka⌬gI, gE staining was observed almost exclusively in neurons, with satellite cells being almost universally gE negative (Fig. 5E) . No VZV-specific staining was observed within mock-infected DRG (Fig. 5F ). These results indicate that rOka⌬gI is impaired in cell-to-cell spread of VZV within intact DRG.
NCAM expression is disrupted during VZV infection and is dependent on gI. As disruption of the gE/gI complex has previously been shown to inhibit VZV-induced membrane fusion of neuron-satellite cell complexes using the SCIDhu model of infection (11), we sought to determine whether a similar phenotype could be observed in a DRG explant model of VZV infection. Dual-immunofluorescence staining of DRG inoculated with mock-, rOka-, or rOka⌬gI-infected HFFs was performed at 96 h p.i. using antibodies specific to VZV gE in conjunction with NCAM. In mock-infected cells, continuous NCAM staining was readily observed along the membranes of neurons, demarcating the neuron-satellite cell boundary (Fig. 6C) . Quantification of mock-infected neurons revealed that intact NCAM staining was evident surrounding approximately 96% of neurons. In contrast, 53% of rOka-infected neurons exhibited discontinuous or dim NCAM staining, although adjacent VZV gE-negative neurons exhibited staining with intensities and localizations comparable to those of mock-infected cultures (Fig. 6A) . Discontinuous NCAM staining was predominately observed when VZV gE-positive neurons were adjacent to infected satellite cells, as has been previously reported (11, 27) . Neurons infected with rOka⌬gI, however, showed a reduced alteration in NCAM localization and intensity compared with neurons infected with rOka, with only 20% of cells exhibiting aberrant NCAM staining (Fig. 6B) . No specific staining was observed in isotype control antibody-treated cultures (Fig.  6D) . These data illustrate that gI is required for VZV-induced neuron-to-satellite cell fusion during VZV infection of human explant DRG.
DISCUSSION
We assessed the role of VZV gI in mediating the spread of infection in cultures of synaptically linked neuronal cells and human fetal DRG explanted in vitro. A significant impairment of rOka⌬gI spread was observed in both of these models, despite only a conservative reduction in cell-to-cell spread within cultures of permissive HFFs. This report provides evidence that gI is required for axonal localization of VZV virion proteins and suggests a role for gI in facilitating axonal transmission of virus. (D to F) DRG were stained for S100B (green) in conjunction with a VZV gE-specific antibody (red). Cells were counterstained with DAPI (blue).
We observed that VZV glycoproteins localized aberrantly to the TGN in the absence of gI, in agreement with a number of previous studies. Electron microscopy studies of infected human embryonic lung fibroblasts showed that gI is required for VZV envelopment in the TGN, with abnormal membranous TGN stacks formed during rOka⌬gI infection (28) . Experiments using SCIDhu mice with xenografted human DRG similarly confirmed this phenotype within rOka⌬gI-infected neurons, with distorted Golgi apparatus-like cisternae and disruption of gE trafficking observed (10) . We expanded on these findings to also show that the virion components gE, gH, gB, and pORF40 are retained within the TGN and that trafficking of these proteins to axons is disrupted during rOka⌬gI infection of cultured neuronal cells.
Although a chamber system was not employed in this study to separate inoculating cells from newly infected cells, these results indicate that there may be some impairment of VZV axonal transport in the absence of gI. As neurons grown in culture have limited cell-tocell body contact, it is likely that viral infection is mediated at least in part by axonal transmission of virus. Impairment of virion envelopment resulting from gI deletion suggests that the major impediment in rOka⌬gI transport may occur during anterograde viral spread, consistent with the identified roles of gI during HSV and PRV infection (12, 13, 15-17, 29, 30) . Additionally, infection of explanted DRG with rOka⌬gI showed that the ability to infect discrete individual neurons within the ganglion center was retained. Although the possibility that infection within these cells is initiated by infiltrating inoculating cells cannot be completely excluded, it is likely that the large size of fibroblasts prevents their entry into the DRG. It is therefore probable that these cells become infected by axonal transport of virus to the DRG center.
The obstruction of virion protein trafficking to the axons of infected neuronal cells observed is likely to be a consequence of the morphological changes to the TGN resulting from rOka⌬gI infection (10, 28) , although it remains possible that VZV gI is directly required to facilitate virion axonal egress via interactions with vesicles or their molecular motor machinery, as is hypothesized for HSV (13, 31) . Synaptophysin and chromogranin A puncta were still readily observed along the lengths of the axons within our study, illustrating that the functionality of TGN secretory pathways was at least partly retained. Although a model of VZV retrograde transport has recently been reported (22, 32) , a model assessing anterograde spread of virus still remains in developmental stages. Thus, development of more- assessed by dual-immunofluorescence staining. DRG were stained for NCAM (green) in conjunction with a VZV pORF62-specific antibody (red) (A to C) or with isotype control antibodies (D). Cells were counterstained with DAPI (blue). Arrows depict discontinuous NCAM staining on the membranes of VZVinfected neurons adjacent to infected satellite cells. suitable models will be required before these fundamental questions can be directly addressed.
Efficient neuron-to-satellite cell spread of virus within the DRG was dependent on gI. Inspection of rOka-infected DRG at 96 h p.i. revealed that extensive areas of pORF62 staining were visible. Extensive cell-to-cell spread was observed throughout the DRG, with both neurons and S100B antigen-positive satellite cells being infected with VZV. In contrast, pORF62 staining within rOka⌬gI-infected DRG was restricted mainly to isolated neurons within the DRG center, with limited evidence of any viral spread at 96 h p.i. The impairment of VZV spread in the absence of gI supports the findings of a previous study using SCIDhu mice with xenografted human DRG, whereby single rOka⌬gI-infected neurons were observed at 42 days p.i., similarly indicating the impairment of virus spread to neighboring satellite cells (10) . Infection of these DRG with both rOka⌬gI and a virus lacking the cysteine-rich gE/gI binding domain resulted in impaired replication of VZV and an inability to establish persistence for extended time points p.i. (10, 11) . Thus, the neurotropic role of gI characterized in our study is likely to be integrally linked to its ability to heterodimerize with gE.
The SCIDhu model has been used to demonstrate that polykaryon formation between neurons and satellite cell membranes is disrupted during VZV infection, with reduced NCAM expression on the membranes of infected cells observed (11, 27) . It was also shown that deletion of gI or the cysteine-rich region facilitating gE/gI heterodimer formation was able to restore NCAM expression (11) . In our study, we also found that rOka-infected neurons exhibited a downregulation of NCAM expression by immunofluorescence antibody assay (IFA). In contrast, mock-or rOka⌬gI-infected DRG retained strong NCAM staining localized to the membranes of neuron-satellite cell junctions, similarly indicating that rOka⌬gI may be impaired for polykaryon formation. The restriction of NCAM to neural tissue may assist in explaining the cell type-specific impairment of infection resulting from rOka⌬gI infection. Although a small reduction in VZV rOka⌬gI infection was observed in cultures of HFFs over a 72-h time course compared with parental-virus infection, it has been shown that free nucleocapsids within the cytosol are able to fuse with adjacent cells to potentiate infection (28) . It is possible that the gI-mediated inhibition of NCAM downregulation inhibits cell fusion and therefore prevents the transmission of these free cytosolic nucleocapsids to neighboring cells.
In summary, this report details a neurotropic role of VZV glycoprotein I in facilitating the axonal localization of virion proteins and virus spread between cultured neuronal cells. Additional experiments performed using an explanted-DRG model of productive VZV infection confirmed that neuron-to-satellite cell spread of virus and NCAM expression was impaired in the absence of gI. These results will aid in our understanding of VZV neuropathogenesis and the requirements for productive neuronal infection within the DRG that is characteristic of reactivation. They also validate the combined use of SH-SY5Y and primary DRG models of infection to more rapidly facilitate definition of the roles of VZV gene products in neuronal infection.
